Meaningfully connecting with the target audience has become more complex and crucial for pharmaceutical companies than ever before. Traditional methods of engaging healthcare physicians (HCPs), like face-to-face interactions, are being reshaped by digital channels. This shift underscores the need for pharma companies to adapt their marketing strategies to meet their customers' changing preferences and behaviors.
Our case study illustrates the transformative journey of a top-ten pharma company as it navigates the intersection of traditional and digital marketing channels. In a dynamic market where online interactions are omnipresent and digital platforms are prominent, the ability to seamlessly integrate these channels with conventional approaches is a crucial differentiator for marketing success.
The challenges faced by the pharma company were significant. From managing disparate channels and fragmented customer engagement to optimizing efforts in the face of rapid market changes, achieving marketing excellence was difficult.
In this case study, we explore how this pharma giant, in partnership with Axtria, strategically balanced traditional methodologies, digital innovations, and advanced data analytics to achieve omnichannel marketing excellence. Discover how this convergence led to tangible benefits, including:
- Up to 10% lift in return on investment from an omnichannel-led digital engagement.
- Churn prevention, cost reduction, and sales maximization by identifying approximately 8%-12% of HCPs moving across the adoption ladder each month.
- Predictive analytics-backed recommendations to increase customer lifetime value.
- Exponential growth, expanding to encompass over 20 channels and vendors.
This case study demonstrates the effectiveness of integrating traditional and digital marketing with data-driven insights, enabling pharma companies to thrive amidst industry changes.
Download the case study to learn more.
.jpg?width=454&height=645&name=Up%20to%2010%25%20Higher%20Return%20on%20Investment%20(ROI).jpg)
